Concepedia

Publication | Open Access

Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study

DOIFull Paper Access

27

Citations

5

References

2022

Year

Andrew J.K. Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Wenjing Lü, Zailong Wang, Ahmed M. Soliman, Ann Eldred,
Lara D. Veeken

Abstract

United States National Library of Medicine clinical trials database www.clinicaltrials.gov; KEEPsAKE 2; NCT03671148.

References

YearCitations

Page 1